441 related articles for article (PubMed ID: 32860894)
21. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.
Seki H; Tani Y; Arita M
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):126-30. PubMed ID: 19737659
[TBL] [Abstract][Full Text] [Related]
22. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
23. n-3 Docosapentaenoic Acid Intake and Relationship with Plasma Long-Chain n-3 Fatty Acid Concentrations in the United States: NHANES 2003-2014.
Richter CK; Bisselou KS; Nordgren TM; Smith L; Appiah AK; Hein N; Anderson-Berry A; Kris-Etherton P; Hanson C; Skulas-Ray AC
Lipids; 2019 Apr; 54(4):221-230. PubMed ID: 31025717
[TBL] [Abstract][Full Text] [Related]
24. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
25. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
Souza PR; Norling LV
Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764
[TBL] [Abstract][Full Text] [Related]
26. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084
[TBL] [Abstract][Full Text] [Related]
27. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN; Gotlinger K; Hong S; Arita M
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
[TBL] [Abstract][Full Text] [Related]
28. Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes.
Caron JP; Gandy JC; Brown JL; Sordillo LM
Prostaglandins Other Lipid Mediat; 2019 Jun; 142():1-8. PubMed ID: 30836143
[TBL] [Abstract][Full Text] [Related]
29. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
Serhan CN; Arita M; Hong S; Gotlinger K
Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828
[TBL] [Abstract][Full Text] [Related]
30. EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.
So J; Wu D; Lichtenstein AH; Tai AK; Matthan NR; Maddipati KR; Lamon-Fava S
Atherosclerosis; 2021 Jan; 316():90-98. PubMed ID: 33303222
[TBL] [Abstract][Full Text] [Related]
31. Specialised pro-resolving mediators of inflammation in inflammatory arthritis.
Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423
[TBL] [Abstract][Full Text] [Related]
32. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
Al-Shaer AE; Buddenbaum N; Shaikh SR
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
[TBL] [Abstract][Full Text] [Related]
33. The Omega-3 Fatty Acids EPA and DHA, as a Part of a Murine High-Fat Diet, Reduced Lipid Accumulation in Brown and White Adipose Tissues.
Soni N; Ross AB; Scheers N; Nookaew I; Gabrielsson BG; Sandberg AS
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771283
[TBL] [Abstract][Full Text] [Related]
34. Specialized pro-resolving mediator network: an update on production and actions.
Chiang N; Serhan CN
Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
[TBL] [Abstract][Full Text] [Related]
35. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.
Chiang N; Serhan CN
Methods Mol Biol; 2006; 341():227-50. PubMed ID: 16799203
[TBL] [Abstract][Full Text] [Related]
36. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
[TBL] [Abstract][Full Text] [Related]
38. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
[TBL] [Abstract][Full Text] [Related]
39. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
40. Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.
Beyer MP; Videla LA; Farías C; Valenzuela R
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
